-
Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic
Journal of the National Comprehensive Cancer Network, 2014
-
A single-field integrated boost treatment planning technique for spot scanning proton therapy
Radiation Oncology, 2014
-
Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance
Medical Physics, 2013
-
Establishing and expanding the indications for proton and particle therapy
Acta Oncologica, 2013
-
Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors
Medical Dosimetry, 2013
-
A Fully Automated Method for CT-on-Rails-Guided Online Adaptive Planning for Prostate Cancer Intensity Modulated Radiation Therapy
International Journal of Radiation Oncology, 2013
-
Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients
Prostate Cancer and Prostatic Diseases, 2013
-
Statistical Assessment of Proton Treatment Plans under Setup and Range Uncertainties
International Journal of Radiation Oncology, 2013
-
Declining use of brachytherapy for the treatment of prostate cancer
Brachytherapy, 2013
-
Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer
Practical Radiation Oncology, 2013
-
Core Physics Competencies for Proton Therapy Training of Radiation Oncology and Medical Physics Residents and Fellows
International Journal of Radiation Oncology, 2013
-
Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer
International Journal of Radiation Oncology, 2013
-
Dosimetric Effects of Weight Loss or Gain During Volumetric-Modulated Arc Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer
Medical Dosimetry, 2013
-
Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?
International Journal of Radiation Oncology , 2012
-
Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?
European Journal of Cancer, 2012
-
Screening Colonoscopy Before Prostate Cancer Treatment Can Detect Colorectal Cancers in Asymptomatic Patients and Reduce the Rate of Complications After Brachytherapy
Practical Radiation Oncology, 2012
-
Uncertainty incorporated beam angle optimization for IMPT treatment planning
Medical Physics, 2012
-
Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer
Annals of Oncology, 2012
-
Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy
Journal of Applied Clinical Medical Physics, 2012
-
In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors
Radiation Measurements, 2012
-
Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer
Physics in Medicine and Biology, 2012
-
PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era
International Journal of Radiation Oncology, 2012
-
Verification of proton range, position, and intensity in IMPT with a 3D liquid scintillator detector system
Medical Physics, 2012
-
Proton beam therapy for the treatment of prostate cancer
Practical Radiation Oncology, 2012
-
A Comprehensive Comparison of IMRT and VMAT Plan Quality for Prostate Cancer Treatment
International Journal of Radiation Oncology, 2012
-
Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy
Brachytherapy, 2012
-
Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy
Physica Medica, 2011
-
Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches
Journal of Applied Clinical Medical Physics, 2011
-
Long-term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease?
International Journal of Radiation Oncology, 2011
-
Patient-Specific Quality Assurance for Prostate Cancer Patients Receiving Spot Scanning Proton Therapy Using Single-Field Uniform Dose
International Journal of Radiation Oncology, 2011
-
Role of radiation therapy for the treatment of lymph nodes in urologic malignancies
Urologic Clinics of North America, 2011
-
Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer
Journal of Drug, Healthcare and Patient Safety, 2011
-
A Beam-specific Planning Target Volume (PTV) Design for Proton Therapy to Account for Setup and Range Uncertainties
International Journal of Radiation Oncology, 2011
-
A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity-modulated radiation therapy
American Journal of Clinical Oncology, 2010
-
Toward a real-time in vivo dosimetry system using plastic scintillation detectors
International Journal of Radiation Oncology, 2010
-
Spot Scanning Proton Beam Therapy for Prostate Cancer: Treatment Planning Technique and Analysis of Consequences of Rotational and Translational Alignment Errors
International Journal of Radiation Oncology, 2010
-
Late Rectal Toxicity on RTOG 94-06: Analysis Using a Mixture Lyman Model
International Journal of Radiation Oncology, 2010
-
Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer
Physics in Medicine and Biology, 2010
-
Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy
Journal of Urology, 2009
-
Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer
International Journal of Radiation Oncology, 2009
-
The MD Anderson Proton Therapy System
Medical Physics, 2009
-
Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience
Urology, 2009
-
Dosimetric Changes Resulting From Patient Rotational Setup Errors in Proton Therapy Prostate Plans
International Journal of Radiation Oncology, 2008
-
Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?
Urologic Oncology, 2008
-
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
International Journal of Radiation Oncology, 2008
-
Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer
Physics in Medicine and Biology, 2008
-
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time
Journal of Urology, 2008
-
Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer
International Journal of Radiation Oncology, 2007
-
Commentary on "Cancer Specific Mortality After Radiation Therapy with Short-Course Hormonal Therapy or Radical Prostatectomy in Men with Localized, Intermediate-Risk to High-Risk Prostate Cancer"
The American Journal of Hematology/Oncology, 2007
-
Implication of CT table sag on geometrical accuracy during virtual simulation
Medical Dosimetry, 2007
-
Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer
International Journal of Radiation Oncology, 2007
-
Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?
Radiotherapy & Oncology, 2007
-
Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate
Physics in Medicine and Biology, 2007
-
Using prostate-specific antigen doubling time in clinical practice
BJU International, 2007
-
Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment
International Journal of Radiation Oncology , 2007
-
Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?
BJU International, 2007
-
Reducing metal artifacts in cone-beam CT images by preprocessing projection data
International Journal of Radiation Oncology, 2006
-
Late gastrointestinal toxicity after radiation for prostate cancer
Cancer, 2006
-
Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
Cancer, 2006
-
Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer
Cancer, 2006
-
Update on radiation therapy in prostate cancer
Hematology/Oncology Clinics of North America, 2006
-
Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy
International Journal of Radiation Oncology , 2006
-
Radiation therapy combined with hormone therapy for prostate cancer
Seminars in Radiation Oncology, 2006
-
Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy
International Journal of Radiation Oncology, 2005
-
Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy
International Journal of Radiation Oncology, 2005
-
Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy
International Journal of Radiation Oncology, 2005
-
Symptomatic local recurrence of prostate carcinoma after radiation therapy
Cancer, 2005
-
Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?
Urology, 2005
-
Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy
International Journal of Radiation Oncology, 2005
-
Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy
International Journal of Radiation Oncology, 2005
-
Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy
Journal of Clinical Oncology, 2005
-
Comparison of treatment volumes and techniques in prostate cancer radiation therapy
American Journal of Clinical Oncology, 2005
-
Mortality after cure of testicular seminoma
Journal of Clinical Oncology, 2004
-
In vivo tumor imaging in mice with near-infrared labeled endostatin
Molecular Cancer Therapeutics, 2004
-
Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study
International Journal of Radiation Oncology, 2004
-
Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure
Urology, 2004
-
Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer
Journal of the National Medical Association, 2004
-
Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?
Urologic Oncology, 2003
-
Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma
International Journal of Radiation Oncology, 2003
-
Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate
Journal of Urology, 2003
-
Current results of brachytherapy for soft tissue sarcoma
Current Opinion in Oncology, 2003
-
Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer
International Journal of Radiation Oncology, 2003
-
Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancer
International Journal of Radiation Oncology, 2003
-
Uncertainties in physical and biological targeting with radiation therapy
Rays, 2003
-
Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer
Journal of Urology, 2002
-
Optimizing patient selection for prostate monotherapy
International Journal of Radiation Oncology, 2001
-
Stereotactic radiosurgery for patients with single brain metastasis
Journal of Radiosurgery, 1998
-
Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver
Cell Biology and Toxicology, 1997